Zealthy- Kyt Ventures Backs Women Centric Vernacular Healthcare Platform
Zealthy, a women centric vernacular healthcare platform, has raised an undisclosed amount in seed round from Kyt ventures, First Cheque, AngelList and few prominent angel investors.
The Bengaluru based startup plans to use the funding to further develop its product and technology offering, include more Indian languages and bolster its tier 2, 3 cities base across India.
Started in 2019 by Dr Rishi Malhotra and Akhil Gupta, Zealthy is a holistic and trustworthy women-only platform to understand, share and learn health issues specific to women in their local languages. It connects users to reliable healthcare providers for specialties like maternity, infertility, cosmetic interventions etc. at affordable prices.
Dr Anu Gupta, Co-founder Kyt Ventures said, “Being a doctor and a woman, I could see how Zealthy’s women centricity, Tier 2/3 focus and vernacular strategy have the potential to lead the next phase of digital health in India.”
Zealthy claims to have over 5 million google impressions. Interestingly, 70% of the searches coming from Tier 2 and Tier 3 cities are in vernacular language. The startup already has a footprint across 15+ cities and has partnered with few of the prominent names including Apollo cradle, Milann, Morpheus, Motherhood and other maternity homes.
Consumption healthcare is a $40 billion market with a CAGR of more than 20%. It is huge, fragmented, highly competitive and lacks targeted customer acquisition channels which presents an opportunity for disruption.
The mHealth sector alone is expected to grow to $1.6B by 2022. While Practo, Lybrate, mfine, DocsApp are the key players providing online health services, players like MyUpchar differentiates itself by providing health information in vernacular languages and Elawoman has a special focus on infertility services.
Gagan Gupta, Co-founder Kyt Ventures said that Zealthy team with its mobile plus internet plus vernacular strategy, is well poised to make a major impact in the fem-tech segment.
